Frontlight ResearchEarly access
Trial site
Akershus universitetssykehus
- 5running trials
- 3closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer3 trials
- Ulcerative colitis3 trials
- Acute myeloid leukaemia1 trial
- Cervical cancer1 trial
- Crohn's disease1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Myelodysplastic syndromes1 trial
- and 3 more
- Phase
- Phase 23 trials
- Phase 32 trials
- Phase 2/31 trial
- Status
- Active, not recruiting2 trials
- Completed2 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Alfasigma S.p.A.1 trial
- Bristol-Myers Squibb1 trial
- Daiichi Sankyo1 trial
- Eli Lilly and Company1 trial
- Hoffmann-La Roche1 trial
- and 3 more
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Precision Therapy Versus Standard Therapy in AML and MDS in Elderly
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Bladder cancer1 recruiting
- Crohn's disease1 recruiting
- Myelodysplastic syndromes1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Completed
Terminated
Site data: ClinicalTrials.govUpdated 12 Nov 2026